Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for th... Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company’s lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K? inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.03 | 0.226244343891 | 13.26 | 13.89 | 12.835 | 7960 | 13.16235176 | DR |
| 4 | 0.66 | 5.22565320665 | 12.63 | 13.89 | 11.96 | 6968 | 12.72212464 | DR |
| 12 | -3.24 | -19.6007259528 | 16.53 | 18.41 | 11.8301 | 11275 | 14.00428117 | DR |
| 26 | -3.64 | -21.5002953337 | 16.93 | 21.34 | 11.8301 | 19862 | 16.25500698 | DR |
| 52 | 2.62 | 24.5548266167 | 10.67 | 21.34 | 9.5354 | 17153 | 15.7146142 | DR |
| 156 | 1.53 | 13.0102040816 | 11.76 | 21.34 | 6.65 | 8754 | 13.53350916 | DR |
| 260 | 1.7 | 14.6678170837 | 11.59 | 21.34 | 6.1 | 8203 | 12.7592496 | DR |
flushes
6分前
Whalatane
7分前
flushes
9分前
flushes
10分前
superman2026
11分前
Jack_Bolander
12分前
catdaddy
13分前
Pittsburgh Boy
14分前
Harbor6460
27分前
sharkey1
27分前
sharkey1
29分前
researcher59
31分前
Oleblue
31分前
TightCoil
31分前
Pittsburgh Boy
34分前
FUNYMUNY
35分前
Paullee
39分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。